Form 4: LeMaitre Vascular Inc. Executive Trent G. Kamke Reports Acquisition of Dividend Equivalent Rights
SEC Form 4 Filing
Trent G. Kamke, Senior VP of Operations at LeMaitre Vascular Inc., reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.
Summary
- On August 29, 2024, Trent G. Kamke, Senior VP of Operations at LeMaitre Vascular Inc., acquired dividend equivalent rights.
- These rights are associated with previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
- The dividend equivalent rights vest proportionately with the underlying awards and are economically equivalent to shares of LeMaitre Vascular Inc.'s common stock.
- The acquisitions include 0.3084 rights related to a 2019 RSU award, 0.5764 rights related to a 2020 RSU award, 1.0706 rights related to a 2021 RSU award, 1.6377 rights related to a 2022 RSU award, 1.6377 rights related to a 2022 PSU award, and 1.8658 rights related to a 2023 RSU award.
- Following these transactions, Kamke directly owns 9.7055, 13.3733, 17.6227, 14.6871, 14.6787 and 6.4422 dividend equivalent rights respectively.
Sentiment
Score: 7
Explanation: The document is a neutral regulatory filing detailing standard executive compensation practices. It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It provides transparency into the equity-based compensation of key personnel.
Stakeholder Impact
- The acquisition of dividend equivalent rights has a minor positive impact on the executive, aligning their interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 12/20/2019 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/02/2020 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/11/2021 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/12/2022 | Date of restricted stock unit and performance share unit award grants related to dividend equivalent rights. |
| 12/08/2023 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 08/29/2024 | Date of transaction: Acquisition of dividend equivalent rights. |
| 09/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.